Spark Therapeutics, Inc. (ONCE): Bullish Rating Reiterated

ONCE – Credit Suisse reiterates Outperform rating; PT raised to $75 from $61. This price target represents a 16.28% upside over the stock’s previous closing price of $64.50.

Update: As of Dec. 13, 2018, this bullish analyst call has returned -39.10%.

Key Facts Surrounding This News Item

  • ONCE had a POWR Rating of C (Neutral) coming into today.
  • ONCE was 7.14% above its 10-Day Moving Average coming into today.
  • ONCE was 13.73% above its 20-Day Moving Average coming into today.
  • ONCE was 17.08% above its 50-Day Moving Average coming into today.
  • ONCE was 1.83% above its 100-Day Moving Average coming into today.
  • ONCE was -3.93% below its 200-Day Moving Average coming into today.
  • ONCE had returned +25.44% year-to-date leading up to today’s news, versus a +2.22% return from the benchmark S&P 500 during the same period.

More Info About Spark Therapeutics, Inc. (ONCE)

Spark Therapeutics is a gene therapy leader seeking to transform the lives of patients suffering from debilitating genetic diseases by developing one-time, life-altering treatments. The company was founded in 2013 and is based in Philadelphia, Pennsylvania. View our full ONCE ticker page with ratings, news, and more.

ONCE at a Glance

ONCE Current POWR Rating™
Overall POWR Rating™
ONCE Current Price $39.28 4.94%
More ONCE Ratings, Data, and News

ONCE Price Reaction

The day of this event (Mar. 8, 2018)
ONCE Closing Price$62.72 2.76%
ONCE Volume563,700
4.47% from avg
Leading up to this event
ONCE 1-mo return26.40%
After this event
ONCE 1-day return4.74%
ONCE 3-day return1.37%
ONCE 5-day return0.62%

ONCE Price Chart

The Top Stocks For 2019

More Spark Therapeutics, Inc. (ONCE) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All ONCE News
Page generated in 0.8464 seconds.